Biblio

Export 1991 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is B  [Clear All Filters]
2016
A. Boehm-Cagan, Bar, R., Liraz, O., Bielicki, J. K., Johansson, J. O., and Michaelson, D. M., “ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1219-1233, 2016.
J. Dukart, Sambataro, F., and Bertolino, A., “Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1143-59, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
A. Tramutola, Pupo, G., Di Domenico, F., Barone, E., Arena, A., Lanzillotta, C., Broekaart, D., Blarzino, C., Head, E., D Butterfield, A., and Perluigi, M., “Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.”, J Alzheimers Dis, vol. 52, no. 1, pp. 359-71, 2016.
R. L. H. Handels, Joore, M. A., Vos, S. J. B., Aalten, P., Ramakers, I. H. G. B., Rikkert, M. Olde, Scheltens, P., Jansen, W. J., Visser, P. - J., van Berckel, B. M. N., van Domburg, P., Smid, M., Hoff, E., Hoogmoed, J., Bouwman, F., Claassen, J., Leentjens, A. F. G., Wolfs, C. A. G., Severens, J. L., and Verhey, F. R. J., “Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort.”, J Alzheimers Dis, vol. 52, no. 3, pp. 875-85, 2016.
T. Minh Do, Dodacki, A., Alata, W., Calon, F., Nicolic, S., Scherrmann, J. - M., Farinotti, R., and Bourasset, F., “Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).”, J Alzheimers Dis, vol. 49, no. 2, pp. 287-300, 2016.
S. Matura, Prvulovic, D., Hartmann, D., Scheibe, M., Sepanski, B., Butz, M., Oertel-Knöchel, V., Knöchel, C., Karakaya, T., Fußer, F., Hattingen, E., and Pantel, J., “Age-Related Effects of the Apolipoprotein E Gene on Brain Function.”, J Alzheimers Dis, vol. 52, no. 1, pp. 317-31, 2016.
M. Heffernan, Mather, K. A., Xu, J., Assareh, A. A., Kochan, N. A., Reppermund, S., Draper, B., Trollor, J. N., Sachdev, P., and Brodaty, H., “Alcohol Consumption and Incident Dementia: Evidence from the Sydney Memory and Ageing Study.”, J Alzheimers Dis, vol. 52, no. 2, pp. 529-38, 2016.
Y. Oboshi, Kikuchi, M., Terada, T., Yoshikawa, E., Bunai, T., and Ouchi, Y., “Alterations in Phase-Related Prefrontal Activation During Cognitive Tasks and Nicotinic α4β2 Receptor Availability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 3, pp. 817-30, 2016.
P. Joussain, Bessy, M., Fournel, A., Ferdenzi, C., Rouby, C., Delphin-Combe, F., Krolak-Salmon, P., and Bensafi, M., “Altered Affective Evaluations of Smells in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
P. Joussain, Bessy, M., Fournel, A., Ferdenzi, C., Rouby, C., Delphin-Combe, F., Krolak-Salmon, P., and Bensafi, M., “Altered Affective Evaluations of Smells in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
J. Yu, Li, R., Jiang, Y., Broster, L. S., and Li, J., “Altered Brain Activities Associated with Neural Repetition Effects in Mild Cognitive Impairment Patients.”, J Alzheimers Dis, vol. 53, no. 2, pp. 693-704, 2016.
M. Perkins, Wolf, A. B., Chavira, B., Shonebarger, D., Meckel, J. P., Leung, L., Ballina, L., Ly, S., Saini, A., T Jones, B., Vallejo, J., Jentarra, G., and Valla, J., “Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.”, J Alzheimers Dis, vol. 53, no. 1, pp. 95-106, 2016.
A. V. Morozov, Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen'ev, M. B., Sharova, N. P., Karpov, V. L., and Makarov, A. A., “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
M. Jeong Wang, Yi, S. H., Han, J. - Y., Park, S. Young, Jang, J. - W., Chun, I. Kook, Van Giau, V., Bagyinszky, E., Lim, K. Taek, Kang, S. Min, An, S. Soo A., Park, Y. Ho, Youn, Y. Chul, and Kim, S. Y., “Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1403-13, 2016.
B. A. Ardekani, Convit, A., and Bachman, A. H., “Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression.”, J Alzheimers Dis, vol. 50, no. 3, pp. 847-57, 2016.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., “Anemia and Mild Cognitive Impairment in the German General Population.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
A. Belkacemi and Ramassamy, C., “Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State.”, J Alzheimers Dis, vol. 50, no. 4, pp. 981-98, 2016.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., “The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., “The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
M. Stravalaci, Tapella, L., Beeg, M., Rossi, A., Joshi, P., Pizzi, E., Mazzanti, M., Balducci, C., Forloni, G., Biasini, E., Salmona, M., Diomede, L., Chiesa, R., and Gobbi, M., “The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1485-97, 2016.
K. Bourgade, Dupuis, G., Frost, E. H., and Fülöp, T., “Anti-Viral Properties of Amyloid-β Peptides.”, J Alzheimers Dis, vol. 54, no. 3, pp. 859-878, 2016.
M. Mandecka, Budziszewska, M., Barczak, A., Pepłońska, B., Chodakowska-Żebrowska, M., Filipek-Gliszczyńska, A., Nesteruk, M., Styczyńska, M., Barcikowska, M., and Gabryelewicz, T., “Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 157-68, 2016.

Pages